Injectable Drug Delivery Market 

  • Administration of drugs to manage prevailing diseases is a general process followed across the globe. The injectable drug delivery includes the use of needles or similar objects that are penetrated the skin for the administration of the drug.
  • Continuous innovations are subjected to improve the experience of patients during injectable drug delivery with the help of certain reminders, self-use of devices, connectivity of smartphones and others.

  • Moreover, the currents self-injection devices including pen injectors and needle-free injectors have made the injectable drug delivery comparatively easier.
  • The global injectable drug delivery market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.

 

Injectable Drug Delivery Market Drivers

  • Increase in prevalence of chronic diseases, extensive usage of biologics, the convenience offered by the syringes and the ease of dispensing the drug at the exact proportions are driving the global injectables drug delivery market.
  • The increase in the prevalence of cancer and diabetes in recent years where the injectable drugs are used in the treatment and the current trend in developing the safety syringes, prefilled syringes and autoinjectors are amplifying the market.
  • The prevalence of the self-care trend where patients prefer drug administration in the convenience of their home deprived of any medical assistance is further boosting new developments in the injectable drug delivery landscape.
  • Major factors hindering the global injectable drug delivery market are the presence of alternatives to drug delivery methods and safety concerns due to the increase in needle sticks during treatment.

 

Injectable Drug Delivery Market Segmentation Analysis

  • Global injectable drug delivery market is segmented by product type includes devices and formulations; by packaging type, includes ampul, bottle, cartridges, others.
  • The therapeutic type includes autoimmune disease, hormonal disorders, orphan disease, cancer drugs, and other therapeutic diseases; by route of administration includes intradermal, central nervous system, and others and by distribution channel includes online pharmacies, retail pharmacies, hospital pharmacies, and others.
  • The formulation technologies segment dominate the global injectable drug delivery market due to rapid developments in nanotechnologies has yielded advancements in targeted drug delivery carriers such as liposomes, microspheres and polymeric micelles.
  • The increase in the need for targeted and sustained drug delivery in the treatment of chronic diseases and cost-effective delivery for high priced medicines.

 

Injectable Drug Delivery Market Geographical Share

  • The global injectable drug delivery market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East and Africa
  • North America dominates the global injectable drug delivery market due to a rise in incidences of cardiovascular, arthritis & autoimmune diseases, high patient compliance for injectable drug delivery devices, growing geriatric population as they are prone to frequent health disorders and require treatment, where these injectable are frequently used, are driving the global injectable drug delivery market.

  • According to RAND Corporation in 2017, 60% of U.S adults are living with one form of chronic disease, and 42 are leaving with more than one type of chronic disease.
  • According to the American Autoimmune Related Diseases Association Inc, in 2017 estimated that about 5o million or 20% population or one in five in America are suffering from autoimmune disease and 3/4th of that constitutes to women.
  • According to the Centers Of Disease Control And Prevention in 2017 estimated that 54.4 million u.s adults are living with arthritis and estimated to increase about 78million (28%) by 2040.
  • China and India are estimated to be the fastest growing region in global injectable drug delivery market due to an increase in healthcare expenditure, rise in healthcare awareness, a large pool of patients and increase in government funding.

 

Injectable Drug Delivery Market Competitive Trends

  • Mergers between the key players and research organizations in the development of novel devices and recent FDA approval in advanced injectors are driving the global injectable drug delivery market.
  • In November 2018, Enable Injections made a strategic partnership with UCB and Apellis Pharmaceuticals for the development of patient-centric drug delivery.
  • In August 2018, Antreas Pharma received FDA approval for generic EpiPen Utilizing VIBEX AutoInjector.
  • In February 2018, Sandoz got FDA approval for generic and injectable MS drug to treat replacing forms of multiple sclerosis.
  • In November 2017, SHL Group and NYC Startup QuiO merged to Forge the Next Generation of Self-Treatment.
  • In July 2017, Baxter Acquired Claris Injectables to expand its Generic Injectable Medicines Portfolio.
  • Major market players in Injectable Drug DeliveryBecton Dickinson & Company, Baxter International, Inc., Gerresheimer AG, Pfizer, Inc., Schott AG, Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceutical Industries Ltd and Others.

 

Target Audience:

  • Equipment Suppliers/ Buyers
  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Global Injectable Drug Delivery Market

Section 1. Injectable Drug Delivery Market - Methodology and Scope

1.1 Research methodology

1.2 Research Objective and Scope of the Report

Section 2. Injectable Drug Delivery Market - Industry Trends

Section 3. Injectable Drug Delivery Market Outlook

3.1 Market Snippet by Product Type

3.2 Market Snippet by Packaging

3.3 Market Set Snippet by Distribution Channel

3.5 Market Snippet by Region

3.6 DataM CLO Scenario

Section 4. Injectable Drug Delivery Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunity

4.4 Impact Analysis

Section 5. Injectable Drug Delivery Market - Industry Forces

5.1 Supply Chain Analysis

5.2 Pricing Analysis

5.3 Key Companies to Watch

5.4 Technology Developments

5.5 Epidemiology

5.6 PORTERS Five Forces

5.7 Product Adoption Rate

5.8 Regulations

Section 6. Injectable Drug Delivery Market Segmentation Analysis - By Product Type

6.1 Devices

6.1.1 Conventional injection devices

6.1.2 Self-injection devices

6.1.3 Autoinjectors

6.1.4 Pen Injectors

6.1.5 Wearable injectors

6.1.6 Other devices

6.2 Formulations

6.2.1 Conventional drug delivery formulation

6.2.1.1 Solutions

6.2.1.2 Reconstituted/Lyophilized Formulations

6.2.1.3 Suspensions

6.2.1.4 Emulsions

6.2.2 Novel drug formulations

6.2.2.1 Niosomes

6.2.2.2 Liposomes

6.2.2.3 Polymeric/mixed cells

6.2.2.4 Microparticles 

Section 7. Injectable Drug Delivery Market Segmentation Analysis - By Packaging

7.1 Vials

7.2 Ampule

7.3 Bottle

7.4 Cartridges

7.5 Others

Section 8. Injectable Drug Delivery Market Segmentation Analysis - By Therapeutic application

8.1 Autoimmune Disease

8.2 Hormonal Disorders

8.3 Orphan disease

8.4 Cancer

8.5 Other therapeutic diseases

Section 9. Injectable Drug Delivery Market Segmentation Analysis - By Route of administration

9.1 Intradermal

9.2 Central Nervous System

9.3 Others

Section 10. Injectable Drug Delivery Market Segmentation Analysis - By Distribution Channel

10.1 Online Pharmacies

10.2 Retail pharmacies

10.3 Hospital Pharmacies

10.4 Others

Section 11. Injectable Drug Delivery Market - Regional, Country-level Analysis

11.1 North America

11.1.1 U.S.

11.1.2 Canada

11.1.3 Mexico

11.2 Europe

11.2.1 Germany

11.2.2 U.K.

11.2.3 France

11.2.4 Italy

11.2.5 Spain

11.2.6 Rest of Europe

11.3 South America

11.3.1 Brazil

11.3.2 Argentina

11.3.3 Rest of South America

11.4 Asia Pacific

11.4.1 China

11.4.2 India

11.4.3 Japan

11.4.4 Australia

11.4.5 Rest of Asia Pacific

11.5 Rest of the world

Section 12. Injectable Drug Delivery Market - Competitive Analysis

12.1 Competitor Strategy Analysis

12.2 Comparative Product Portfolio Analysis

12.3 Market Positioning/Share Analysis

12.4 Mergers and Acquisitions Analysis

12.5 Competitive Scenario

Section 13. Injectable Drug Delivery Market - Company Profiles

13.1 Becton Dickinson & Company

13.2 Baxter International, Inc.

13.3 Gerresheimer AG

13.4 Pfizer, Inc.

13.5 Schott AG

13.6 ELI Lilly and Company

13.7 Sandoz (A Division of Novartis AG)

13.8 Terumo Corporation

13.9 Teva Pharmaceutical Industries Ltd.

Section 14. Injectable Drug Delivery Market - Premium Insights

Section 15. Injectable Drug Delivery Market - DataM

15.1 Appendix

15.2 About Us and Services

15.3 Contact Us

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
step 1We collate your requirements.
step 2Our global research team is put into action.
step 3We deliver, and make sure your endeavour is a success!

Buy This Report